Video -
Biogen Idec and Sobi to donate 1 billion international units of clotting factor to support treatment of haemophilia in developing world
Biogen Idec and Sobi intend to produce one billion international units (IUs) of clotting factor therapy for humanitarian aid programs in the developing world. Initially, the companies have committed to donating up to 500 million IUs to the World Federation of Hemophilia over five years to support its efforts to raise the standard of care for people with haemophilia in the developing world.
-
License:
Media Use
The content may be downloaded by journalists, bloggers, columnists, creators of public opinion, etc. It can be used and shared in different media channels to convey, narrate, and comment on your press releases, posts, or information, provided that the content is unmodified. The author or creator shall be attributed to the extent and in the manner required by good practice (this means, for example, that photographers should be attributed).
- File format: .mp4
- Length: 2:35
Topics
- Medical research
Categories
- donation
- humanitarian aid
- haemophilia
- sobi
- biogen idec
- rare diseases
